SPARC™

SPARC™ is the brand name (trademarked by American Medical Systems, or AMS) of a bladder sling — a medical device that is inserted in a patient to support or reinforce internal tissues that have weakened or stretched, causing stress urinary incontinence (SUI) and/or pelvic organ prolapse (POP). SUI is estimated to affect one out of every three women over the age of 45, and POP is estimated to affect one out of every two women over 45.

SPARC™ Is a Bladder Sling

Medical treatments for stress urinary incontinence and pelvic organ prolapse (also called vaginal prolapse) range from non-invasive measures such as biofeedback and medications to extensive surgery. Bladder slings such as the SPARC™ Sling are implanted in a surgical procedure, to hold up the muscles that surround the urethra; the slings are often made of a product called "vaginal mesh."

FDA Investigation of Vaginal Mesh Products

Vaginal mesh has been the focus of several U.S. Food and Drug Administration (FDA) investigations. According to the FDA, it has received thousands of reports of injuries and severe adverse symptoms in women who'd had a bladder sling or other vaginal mesh implant.

A commonly reported injury linked to vaginal mesh is the "erosion" of the mesh, in which the vaginal mesh splits the internal tissues where it was implanted, letting the mesh protrude from the tissue. This can cause very serious bleeding, infections, chronic pain, and the recurrence of the pelvic organ prolapse and/or stress urinary incontinence.

American Medical Systems (which was acquired by Endo Pharmaceuticals in 2011) notes that the SPARC™ sling is "a minimally invasive system that utilizes a suprapubic approach to treat female urinary stress incontinence due to urethral hypermobility and/or intrinsic sphincter deficiency (ISD)." These two conditions are the main causes of stress urinary incontinence.

Learn More about the SPARC™ Sling

Women who are experiencing adverse symptoms of a bladder sling such as the SPARC™ — and women who are afraid of what might happen now that they've had a vaginal mesh product implanted — should learn about their legal options. To learn more, contact our vaginal mesh lawyers today. They are available to investigate potential claims on behalf of women who are injured by vaginal mesh products.

Transvaginal Mesh Litigation

Contact Us

Schedule a free and confidential case review today.

* is a required field

Attorney Advertising:
Flood Law Group, LLP
1101 Pennsylvania Avenue, Suite 600
Washington, DC 20004

Top News

Boston Scientific Faces Thousands of Vaginal Mesh Lawsuits

December 19th, 2013

As transvaginal mesh lawsuits against device maker Boston Scientific Corp. begin to move forward, the company has been directed to bring... read more

J&J Accused of Destroying Vaginal Mesh Documents

December 10th, 2013

As Johnson & Johnson gears up for the first federal vaginal mesh trial, the company faces allegations of destroying or misplacing... read more

Transvaginal Mesh Lawsuit against Boston Scientific to Begin in January 2015

December 4th, 2013

According to reports, a transvaginal mesh lawsuit filed on behalf of a woman who alleges injuries following surgery to correct pelvic... read more

Last Bellwether C.R. Bard Transvaginal Mesh Lawsuit Scheduled for Today

December 3rd, 2013

The latest C.R. Bard transvaginal mesh lawsuit is scheduled for today in the U.S. District Court in West Virginia. This lawsuit... read more

FDA Discusses Risk of Using of Surgical Mesh for POP

August 29th, 2011

The U.S. Food and Drug Administration (FDA) discusses the risks associated with use of transvaginal mesh.

"There are clear risks associated with... read more

Some Doctors Avoid Transvaginal Mesh to Treat POP

August 25th, 2011

In recent years, surgeons have used a device called surgical mesh to support the organs of a woman's pelvis that have... read more

Problems with POP Mesh Surgery Cause Clinical Trial to End Early

August 2nd, 2011

Complications with a medical device used to reinforce the vaginal wall for pelvic organ prolapse (POP) forced researchers to end a... read more